Etanercept Treatment in the Early Course of Polymyalgia Rheumatica - Related Studies

Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

This study is currently recruiting participants.

Study NCT00524381. Last updated on September 2, 2008. Information provided by Bispebjerg Hospital

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Polymyalgia Rheumatica

2	Additional conditions recognized in this trial
		Giant Cell Arteritis

3	More general conditions related to this trial
		Arteritis
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Brain Diseases
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Connective Tissue Diseases
		Immune System Diseases
		Muscular Diseases
		Musculoskeletal Diseases
		Nervous System Diseases
		Rheumatic Diseases
		Skin Diseases
		Skin Diseases, Vascular
		Vascular Diseases
		Vasculitis
		Vasculitis, Central Nervous System

4	Interventions listed in this trial
		Etanercept (Enbrel)
		Sodium chloride (placebo)

5	Additional drug interventions recognized in this trial
		TNFR-Fc fusion protein

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Immunologic Factors
		Immunosuppressive Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Bispebjerg Hospital